Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Phycocyanin, a blue fluorescent phycobiliprotein from Spirulina, is primarily valued for its phycocyanobilin (PCB) chromophore. This active compound drives its potent antioxidant, anti-inflammatory, and anticancer effects through mechanisms like Nrf2 activation and NF-κB inhibition.
Reported Benefits (Provisional)
Origin & History
Phycocyanin is a blue pigment-protein complex extracted from Arthrospira platensis, commonly known as Spirulina. This blue-green microalga, historically consumed by Aztec and Kanembu cultures, is now celebrated worldwide for its vibrant pigment and profound functional health benefits.
Research Narrative (Provisional)
Scientific studies on Phycocyanin from Spirulina are extensive, encompassing in vitro, animal, and some human clinical trials. Research consistently demonstrates its potent antioxidant, anti-inflammatory, immunomodulatory, and neuroprotective effects. Evidence also supports its role in liver protection and enhancing physical performance.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Bioactives: C-Phycocyanin (blue pigment-protein complex), Phycocyanobilin. - Macronutrients: Essential amino acids (as part of the protein complex).
Reported Mechanism (Provisional)
Phycocyanin's primary bioactive compound, phycocyanobilin (PCB), exerts potent antioxidant effects by neutralizing free radicals, scavenging peroxyl and hydroxyl radicals, and inhibiting NADPH oxidase. It activates Nrf2 signaling, increasing endogenous antioxidant enzymes like SOD, catalase, and GSH-Px, while reducing ROS/RNS and lipid peroxidation. Furthermore, Phycocyanin displays strong anti-inflammatory actions by inhibiting NF-κB and MAPK pathways, which leads to reduced pro-inflammatory cytokines like IL-6 and IFN-γ, and increased anti-inflammatory IL-10.
Clinical Narrative (Provisional)
Extensive scientific studies on Phycocyanin from Spirulina, including in vitro, animal, and some human clinical trials, consistently demonstrate its diverse therapeutic potential. Research highlights its potent antioxidant, anti-inflammatory, immunomodulatory, and neuroprotective effects. While many findings are from preclinical models, evidence supports its role in liver protection and cellular health. Further human trials are ongoing to solidify dose-response relationships and long-term efficacy across all benefits.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.